Medicine News and Research

RSS

OHSU study sheds light on ubiquitin modification during bacterial infection

New research from Oregon Health & Science University could one day lead to therapies that prevent or treat diseases and infections tied to a protein that's found in all human cells.

12 Dec 2023

Stem cell therapy trial shows promise for regenerative treatment of heart failure

Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical trial.

12 Dec 2023

PCOS patients can achieve same birth rates with treatment

Researchers from The University of Queensland have found that women with polycystic ovary syndrome (PCOS) respond well to fertility treatments and have the same birth rate as women without the condition.

12 Dec 2023

UK Biobank data shows dose-dependent link between smoking and brain shrinkage

Smoking shrinks the brain, according to a study by researchers at Washington University School of Medicine in St. Louis.

12 Dec 2023

AI model detects atrial fibrillation risk based on subtle ECG variations

A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib)-;an irregular, fast heartbeat that is associated with stroke and heart failure.

12 Dec 2023

Study highlights the necessity to refine the design of randomized cancer drugs trials in China

More than one-eighth of the randomized trials of cancer drugs seeking regulatory approval in China in recent years used inappropriate controls to test the effectiveness and safety of the drugs, according to a new study published December 12th in the open access journal PLOS Medicine by Professor Xiaodong Guan of Peking University, China, and colleagues.

12 Dec 2023

Liquid biopsy may offer new tools for personalized immunotherapy in lung cancer

Using a "liquid biopsy" to study genetic material from tumors shed into the bloodstream together with immune cells could help clinicians predict which patients with advanced lung cancers are responding to immunotherapies and which patients may develop immune-related side effects several months later, according to research directed by investigators at the Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy and Allegheny Health Network Cancer Institute in Pittsburgh.

12 Dec 2023

Daily consumption of prunes may reduce inflammation markers and bone loss effects

A new study published in The Journal of Nutrition shows daily consumption of prunes may reduce inflammation markers connected to bone signaling pathways and reduce the effects of bone loss among postmenopausal women.

12 Dec 2023

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Most patients with Type 2 diabetes will end up needing to add a second-line medication after metformin -; the go-to primary drug for glucose management -; to control their blood sugar levels.

12 Dec 2023

Study unlocks protein clues to aggressive lymphoma transformation

Researchers have come one step closer to answering why, in some patients, a type of lymphoma changes from indolent to aggressive, and in particular they are closer to identifying which patients are at high risk of this change happening.

12 Dec 2023

UVA atlas unveils cellular blueprint of atherosclerosis

University of Virginia School of Medicine researchers have created an "atlas of atherosclerosis" that reveals, at the level of individual cells, critical processes responsible for forming the harmful plaque buildup that causes heart attacks, strokes and coronary artery disease.

12 Dec 2023

Study finds cannabis exposure during pregnancy associated with increased risk of unhealthy outcomes

In the past ten years, the percentage of Americans who use medical marijuana has more than doubled as state-level legalization becomes increasingly common.

12 Dec 2023

New study unlocks hope for immunotherapy in metastatic prostate cancer

Immunotherapy has been disappointing as a prostate cancer treatment, but a new Columbia study suggests that the powerful treatments have potential when the disease starts to spread.

12 Dec 2023

Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

An interview with Dr. Rajas Warke, Director of Molecular Biology and virology at HiMedia Labs.

From Himedia Laboratories Private Limited 12 Dec 2023

PharmaKure and Universiti Teknologi MARA (UiTM) announce partnership to advance research in Alzheimer’s Disease diagnosis

Research partnership aims to build strong pharma and academic collaborations in sharing data and clinical samples to develop biomarker-based diagnostics for Alzheimer’s Disease.

12 Dec 2023

SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel

SolasCure today announced the results of its proof-of-concept, first-in-human, Phase IIa safety study.

From SolasCure 12 Dec 2023

Addressing health inequalities: REP-EQUITY toolkit aims for fairer research representation

Researchers created the REP-EQUITY toolbox for capturing an equitable and representative sample for health research studies.

12 Dec 2023

Research reimagined: Online platform empowers patients and professionals to set rare disease priorities

Patients with rare diseases have traditionally been the subjects of medical research. However, in recent years, their role has begun to shift from 'research participants' to 'experts with a lived experience', with some being involved in study planning, design and interpretation.

11 Dec 2023

New antibody combination shows 'surprising' results in high-risk follicular lymphoma trial

Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine say a new combination of antibody therapies produced a 'surprisingly high' response rate in patients with high-risk follicular lymphoma, a type of non-Hodgkin lymphoma.

11 Dec 2023

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found that people who stopped taking the medication regained much of that weight within a year.

11 Dec 2023

Medicine News and Research

OHSU study sheds light on ubiquitin modification during bacterial infection

Stem cell therapy trial shows promise for regenerative treatment of heart failure

PCOS patients can achieve same birth rates with treatment

UK Biobank data shows dose-dependent link between smoking and brain shrinkage

AI model detects atrial fibrillation risk based on subtle ECG variations

Study highlights the necessity to refine the design of randomized cancer drugs trials in China

Liquid biopsy may offer new tools for personalized immunotherapy in lung cancer

Daily consumption of prunes may reduce inflammation markers and bone loss effects

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Study unlocks protein clues to aggressive lymphoma transformation

UVA atlas unveils cellular blueprint of atherosclerosis

Study finds cannabis exposure during pregnancy associated with increased risk of unhealthy outcomes

New study unlocks hope for immunotherapy in metastatic prostate cancer

Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

PharmaKure and Universiti Teknologi MARA (UiTM) announce partnership to advance research in Alzheimer’s Disease diagnosis

SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel

Addressing health inequalities: REP-EQUITY toolkit aims for fairer research representation

Research reimagined: Online platform empowers patients and professionals to set rare disease priorities

New antibody combination shows 'surprising' results in high-risk follicular lymphoma trial

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News